What Comes Next Could Be a Once-in-a-Lifetime Opportunity

A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.

Click here now to watch the full briefing and discover the steps to take today.

Nicholas Stewart Green net worth and biography

Nicholas Green Biography and Net Worth

CEO of Avid Bioservices

Nicholas Green currently serves as President & CEO of Avid Bioservices and previously served in senior executive roles for several contract manufacturing organizations and life sciences companies, including President & CEO of Therapure Biopharma and Evolve Biologics, Managing Director of Nipa Laboratories Ltd, Head of the Life Sciences Division of Clariant International Ltd, President and CEO of Rhodia Pharma Solutions and President of Codexis Pharma Division. Up until recently Mr. Green was also a Board Member at Induce Biologics Inc and Redrock Regeneration.
Mr. Green holds a BSc (Hons) in chemistry from Queen Mary University of London and an MBA from the University of Huddersfield in the UK. He has more than 30 years of experience in the global pharmaceutical and healthcare services industry with significant expertise in the contract manufacturing of novel pharmaceutical products. His global pharmaceutical experience spans four continents, having run 31 facilities in nine countries spanning North America, South America, Europe, and Asia.

What is Nicholas Stewart Green's net worth?: The estimated net worth of Nicholas Stewart Green is at least $2.78 million as of October 10th, 2024. Mr. Green owns 226,653 shares of Avid Bioservices stock worth more than $2,776,499 as of November 21st. This net worth evaluation does not reflect any other assets that Mr. Green may own. Additionally, Mr. Green receives an annual salary of $699,010.00 as CEO at Avid Bioservices. Learn More about Nicholas Stewart Green's net worth.
How old is Nicholas Stewart Green?: Mr. Green is currently 59 years old. There are 3 older executives and no younger executives at Avid Bioservices. Learn More on Nicholas Stewart Green's age.
What is Nicholas Stewart Green's salary?: As the CEO of Avid Bioservices, Inc., Mr. Green earns $699,010.00 per year. Learn More on Nicholas Stewart Green's salary.
How do I contact Nicholas Stewart Green?: The corporate mailing address for Mr. Green and other Avid Bioservices executives is 2642 Michelle Drive Suite 200, TUSTIN CA, 92780. Avid Bioservices can also be reached via phone at (714) 508-6100 and via email at [email protected]. Learn More on Nicholas Stewart Green's contact information.
Has Nicholas Stewart Green been buying or selling shares of Avid Bioservices?: In the last ninety days, Nicholas Stewart Green has sold $172,588.65 of Avid Bioservices stock. Most recently, Nicholas Stewart Green sold 17,173 shares of the business's stock in a transaction on Thursday, October 10th. The shares were sold at an average price of $10.05, for a transaction totalling $172,588.65. Following the completion of the sale, the chief executive officer now directly owns 226,653 shares of the company's stock, valued at $2,277,862.65. Learn More on Nicholas Stewart Green's trading history.
Who are Avid Bioservices' active insiders?: Avid Bioservices' insider roster includes Mark Bamforth (Director), Nicholas Green (CEO), Richard Hancock (Director), Daniel Hart (CFO), and Mark Ziebell (General Counsel). Learn More on Avid Bioservices' active insiders.
Are insiders buying or selling shares of Avid Bioservices?: In the last twelve months, Avid Bioservices insiders bought shares 1 times. They purchased a total of 23,000 shares worth more than $134,780.00. In the last twelve months, insiders at the biopharmaceutical company sold shares 15 times. They sold a total of 50,858 shares worth more than $423,264.89. The most recent insider tranaction occured on October, 14th when insider Matthew R Kwietniak sold 119 shares worth more than $1,207.85. Insiders at Avid Bioservices own 3.1% of the company. Learn More about insider trades at Avid Bioservices.
Information on this page was last updated on 10/14/2024.

Nicholas Stewart Green Insider Trading History at Avid Bioservices

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/10/2024	Sell	17,173	$10.05	$172,588.65	226,653
7/10/2024	Sell	7,657	$7.54	$57,733.78	212,314
4/30/2024	Sell	11,762	$7.40	$87,038.80	203,606
7/31/2023	Sell	19,519	$12.99	$253,551.81	145,844
7/10/2023	Sell	7,530	$13.77	$103,688.10	127,863
6/29/2023	Sell	40,856	$12.70	$518,871.20	120,067
4/13/2023	Sell	7,000	$20.92	$146,440.00	83,531
4/10/2023	Sell	7,598	$19.80	$150,440.40	90,531
1/10/2023	Sell	8,100	$14.44	$116,964.00	83,729
10/10/2022	Sell	7,493	$17.90	$134,124.70	76,615
8/1/2022	Sell	19,058	$19.22	$366,294.76	69,708
7/11/2022	Sell	2,939	$17.75	$52,167.25	51,266
7/8/2022	Sell	22,725	$17.53	$398,369.25	48,632
4/11/2022	Sell	2,939	$18.56	$54,547.84	28,103
1/10/2022	Sell	3,214	$21.58	$69,358.12
10/11/2021	Sell	2,786	$22.37	$62,322.82
8/2/2021	Sell	18,701	$25.56	$477,997.56	38,553

Nicholas Stewart Green Buying and Selling Activity at Avid Bioservices

Avid Bioservices Company Overview

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.

Today's Range

Now: $12.25

$12.18

$12.33

50 Day Range

MA: $10.98

$9.96

$12.45

2 Week Range

Now: $12.25

$4.07

$12.48

Volume

2,454,736 shs

Average Volume

1,327,359 shs

Market Capitalization

$781.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4

What Comes Next Could Be a Once-in-a-Lifetime Opportunity

From InvestorPlace | Ad

Click here now to watch the full briefing and discover the steps to take today.

Nicholas Green Biography and Net Worth

What is Nicholas Stewart Green's net worth?

How old is Nicholas Stewart Green?

What is Nicholas Stewart Green's salary?

How do I contact Nicholas Stewart Green?

Has Nicholas Stewart Green been buying or selling shares of Avid Bioservices?

Who are Avid Bioservices' active insiders?

Are insiders buying or selling shares of Avid Bioservices?